scholarly journals Postnatal Lifestyle Intervention for Overweight Women With Previous Gestational Diabetes: A Randomized Controlled Trial

2018 ◽  
Vol 103 (7) ◽  
pp. 2478-2487 ◽  
Author(s):  
Valerie A Holmes ◽  
Claire R Draffin ◽  
Chris C Patterson ◽  
Loraine Francis ◽  
Joanne Irwin ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Gestational Diabetes ◽  
Lifestyle Intervention ◽  
Controlled Trial ◽  
Overweight Women ◽  
Randomized Controlled ◽  
Previous Gestational Diabetes

scholarly journals Prevention of gestational diabetes with a prepregnancy lifestyle intervention – findings from a randomized controlled trial

2018 ◽  
Vol Volume 10 ◽  
pp. 493-501 ◽  
Author(s):  
Kristiina Rönö ◽  
Beata Stach-Lempinen ◽  
Johan Gunnar Eriksson ◽  
Maritta Pöyhönen-Alho ◽  
Miira M Klemetti ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Gestational Diabetes ◽  
Lifestyle Intervention ◽  
Controlled Trial ◽  
Randomized Controlled

scholarly journals Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial

2015 ◽  
Vol 29 (19) ◽  
pp. 3234-3237 ◽  
Author(s):  
Angelo Santamaria ◽  
Antonino Di Benedetto ◽  
Elisabetta Petrella ◽  
Basilio Pintaudi ◽  
Francesco Corrado ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Gestational Diabetes ◽  
Controlled Trial ◽  
Overweight Women ◽  
Diabetes Onset ◽  
Randomized Controlled

scholarly journals Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Suzanne Phelan ◽  
Elissa Jelalian ◽  
Donald Coustan ◽  
Aaron B. Caughey ◽  
Kristin Castorino ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Body Weight ◽  
Gestational Diabetes ◽  
Lifestyle Intervention ◽  
Diabetes Prevention ◽  
Controlled Trial ◽  
Overweight And Obesity ◽  
Reduce Body Weight ◽  
Randomized Controlled

Abstract Background Gestational diabetes mellitus (GDM) is associated with several maternal complications in pregnancy, including preeclampsia, preterm labor, need for induction of labor, and cesarean delivery as well as increased long-term risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Intrauterine exposure to GDM raises the risk for complications in offspring as well, including stillbirth, macrosomia, and birth trauma, and long-term risk of metabolic disease. One of the strongest risk factors for GDM is the occurrence of GDM in a prior pregnancy. Preliminary data from epidemiologic and bariatric surgery studies suggest that reducing body weight before pregnancy can prevent the development of GDM, but no adequately powered trial has tested the effects of a maternal lifestyle intervention before pregnancy to reduce body weight and prevent GDM recurrence. Methods The principal aim of the Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional is to determine whether a lifestyle intervention to reduce body weight before pregnancy can reduce GDM recurrence. This two-site trial targets recruitment of 252 women with overweight and obesity who have previous histories of GDM and who plan to have another pregnancy in the next 1–3 years. Women are randomized within site to a comprehensive pre-pregnancy lifestyle intervention to promote weight loss with ongoing treatment until conception or an educational control group. Participants are assessed preconceptionally (at study entry, after 4 months, and at brief quarterly visits until conception), during pregnancy (at 26 weeks’ gestation), and at 6 weeks postpartum. The primary outcome is GDM recurrence, and secondary outcomes include fasting glucose, biomarkers of cardiometabolic disease, prenatal and perinatal complications, and changes over time in weight, diet, physical activity, and psychosocial measures. Discussion The Gestational Diabetes Prevention /Prevención de la Diabetes Gestacional is the first randomized controlled trial to evaluate the effects of a lifestyle intervention delivered before pregnancy to prevent GDM recurrence. If found effective, the proposed lifestyle intervention could lay the groundwork for shifting current treatment practices towards the interconception period and provide evidence-based preconception counseling to optimize reproductive outcomes and prevent GDM and associated health risks. Trial registration ClinicalTrials.gov NCT02763150. Registered on May 5, 2016

scholarly journals Mobile-Based Lifestyle Intervention in Women with Glucose Intolerance after Gestational Diabetes Mellitus (MELINDA), A Multicenter Randomized Controlled Trial: Methodology and Design

2020 ◽  
Vol 9 (8) ◽  
pp. 2635
Author(s):  
Caro Minschart ◽  
Toon Maes ◽  
Christophe De Block ◽  
Inge Van Pottelbergh ◽  
Nele Myngheer ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Randomized Controlled Trial ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Lifestyle Intervention ◽  
Glucose Intolerance ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Multicenter Randomized Controlled Trial

The aims of the ‘Mobile-based lifestyle intervention in women with glucose intolerance after gestational diabetes mellitus (GDM)’ study (MELINDA) are: (1) to evaluate the prevalence and risk factors of glucose intolerance after a recent history of GDM; and (2) to evaluate the efficacy and feasibility of a telephone- and mobile-based lifestyle intervention in women with glucose intolerance after GDM. This is a Belgian multicenter randomized controlled trial (RCT) in seven hospitals with the aim of recruiting 236 women. Women in the intervention group will receive a blended program, based on one face-to-face education session and further follow-up through a mobile application and monthly telephone advice. Women in the control group will receive follow-up as in normal routine with referral to primary care. Participants will receive an oral glucose tolerance test (OGTT) one year after baseline. Primary endpoint is the frequency of weight goal achievement (≥5% weight loss if pre-pregnancy BMI ≥ 25 Kg/m2 or return to pre-gravid weight if BMI < 25 Kg/m2). At each visit blood samples are collected, anthropometric measurements are obtained, and self-administered questionnaires are completed. Recruitment began in May 2019.

scholarly journals Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional

2021 ◽  
Author(s):  
Suzanne Phelan ◽  
Elissa Jelalian ◽  
Donald Coustan ◽  
Kristin Castorino ◽  
Aaron Caughey ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Body Weight ◽  
Gestational Diabetes ◽  
Lifestyle Intervention ◽  
Diabetes Prevention ◽  
Controlled Trial ◽  
Overweight And Obesity ◽  
Reduce Body Weight ◽  
Randomized Controlled

Abstract BackgroundGestational diabetes mellitus (GDM) is associated with several maternal complications in pregnancy, including preeclampsia, preterm labor, need for induction of labor, and cesarean delivery as well as increased long-term risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Intrauterine exposure to GDM raises the risk for complications in offspring as well, including stillbirth, macrosomia, and birth trauma and long-term risk of metabolic disease. One of the strongest risk factors for GDM is the occurrence of GDM in a prior pregnancy. Preliminary data from epidemiologic and bariatric surgery studies suggest that reducing body weight before pregnancy can prevent development of GDM, but no adequately powered trial has tested the effects of a maternal lifestyle intervention before pregnancy to reduce body weight and prevent GDM recurrence.MethodsThe principal aim of Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional is to determine whether a lifestyle intervention to reduce body weight before pregnancy can reduce GDM recurrence. This two-site trial targets recruitment of 252 women with overweight and obesity who have previous histories of GDM and who plan to have another pregnancy in the next 1–3 years. Women are randomized within site to a comprehensive pre-pregnancy lifestyle intervention to promote weight loss with ongoing treatment until conception or an educational control group. Participants are assessed preconceptionally (at study entry, after 4 months, and at brief quarterly visits until conception), during pregnancy (at 26 weeks’ gestation) and at 6 weeks postpartum. The primary outcome is GDM recurrence and secondary outcomes include fasting glucose, biomarkers of cardiometabolic disease, prenatal and perinatal complications, and changes over time in weight, diet, physical activity and psychosocial measures.DiscussionGestational Diabetes Prevention /Prevención de la Diabetes Gestacional is the first randomized controlled trial to evaluate the effects of a lifestyle intervention delivered before pregnancy to prevent GDM recurrence. If found effective, the proposed lifestyle intervention could lay the groundwork for shifting current treatment practices towards the interconception period and provide evidence-based preconception counseling to optimize reproductive outcomes and prevent GDM and associated health risks.Trial registrationClinicalTrials.gov Identifier: NCT02763150

Sign in / Sign up

Export Citation Format

Share Document